The Department of Medicine’s commitment to education is reflected clearly in the opportunities, encouragement and support provided for subspecialty fellow research.
Pulmonary/Critical Care fellows are expected to begin a research project during the first year of training. Research projects are selected based on subspecialty fellow interest and are supervised by a member of the full-time faculty. Five months of protected time for research is given to fellows during their training. Research projects are expected to culminate in presentations at national meetings and/or publications in peer-reviewed journals.
The Division of Pulmonary and Critical Care Medicine provides conference time and funds for each subspecialty fellow to attend a national meeting annually. Over the last few years our fellows have presented at ATS, CHEST, and SCCM.
Currently, the Division is involved in the following clinical trials:
• Clinical Utility of Strados System in recording auscultatory sounds and extending the range and duration of availability of lung sounds after initial clinical assessment
• A real world utility study of Percepta Genomic Sequencing Classifier (GSC) in patients with indeterminate nodules
• Single tube sample collection of transbronchial biopsy samples vs. current process of collecting samples in individual tubes using Envisia, an RNA sequencing assay that uses expression patterns of 190 genes to differentiate between Idiopathic Pulmonary Fibrosis (IPF) and other lung diseases
• A Phase 1/2 Randomized, Placebo-Controlled Trial of ACT-20 in Patients with Moderate to Severe COVID-19 Pneumonia. ACT-20-MSC is a cryopreserved cell therapy product compromised of umbilical-derived mesenchymal stem cells.
• PRE-VENT Study – A Phase 3 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Pacritinib in hospitalized patients with severe COVID-19 with or without cancer